Invasive Infection caused by Streptococcus pneumoniae serotype 6A
Invasive Infection caused by Streptococcus Pneumoniae Serotype 6A
Streptococcus pneumoniae (S. pneumoniae) is a Gram-positive, lancet-shaped bacterium that is commonly found in the human respiratory tract. It includes over 90 different serotypes, however serotype 6A has been identified as a cause of invasive infection, primarily in young children.
Invasive infections caused by S. pneumoniae serotype 6A can include meningitis, sepsis, and bacteremia. If left untreated, these infections can be life-threatening and can lead to long-term health complications. The symptoms of these infections can vary greatly but can include fever, chills, and confusion, as well as other neurological symptoms.
To help prevent invasive infection caused by S. pneumoniae serotype 6A, there are several vaccine choices available in the US and other parts of the world. The current vaccine most commonly used in the US is the pneumococcal conjugate vaccine (PCV). The PCV has been proven to provide protection against several types of S. pneumoniae, including serotype 6A. The PCV is recommended for children in the US beginning at 2 months of age.
In addition to the use of a vaccine, other measures can be taken to help reduce transmission of S. pneumoniae serotype 6A, including:
- washing hands frequently
- disinfecting commonly-used surfaces regularly
- practicing good respiratory hygiene (covering mouth and nose when coughing or sneezing)
- vaccinating children and adults alike against other potentially deadly pneumococcal infections
The S. pneumoniae serotype 6A can cause life-threatening infections, especially in young children. Preventative measures, including vaccination and proper hygiene, are essential for reducing the risk of transmission.
